1. Home
  2. MCVT vs CING Comparison

MCVT vs CING Comparison

Compare MCVT & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCVT
  • CING
  • Stock Information
  • Founded
  • MCVT 2007
  • CING 2012
  • Country
  • MCVT United States
  • CING United States
  • Employees
  • MCVT N/A
  • CING N/A
  • Industry
  • MCVT Finance Companies
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCVT Finance
  • CING Health Care
  • Exchange
  • MCVT Nasdaq
  • CING Nasdaq
  • Market Cap
  • MCVT 11.6M
  • CING 13.5M
  • IPO Year
  • MCVT N/A
  • CING 2021
  • Fundamental
  • Price
  • MCVT $1.93
  • CING $4.10
  • Analyst Decision
  • MCVT
  • CING Strong Buy
  • Analyst Count
  • MCVT 0
  • CING 3
  • Target Price
  • MCVT N/A
  • CING $96.00
  • AVG Volume (30 Days)
  • MCVT 6.0K
  • CING 92.0K
  • Earning Date
  • MCVT 11-12-2024
  • CING 11-07-2024
  • Dividend Yield
  • MCVT N/A
  • CING N/A
  • EPS Growth
  • MCVT N/A
  • CING N/A
  • EPS
  • MCVT 0.05
  • CING N/A
  • Revenue
  • MCVT $3,234,265.00
  • CING N/A
  • Revenue This Year
  • MCVT N/A
  • CING N/A
  • Revenue Next Year
  • MCVT N/A
  • CING N/A
  • P/E Ratio
  • MCVT $39.69
  • CING N/A
  • Revenue Growth
  • MCVT N/A
  • CING N/A
  • 52 Week Low
  • MCVT $1.75
  • CING $1.80
  • 52 Week High
  • MCVT $3.88
  • CING $152.40
  • Technical
  • Relative Strength Index (RSI)
  • MCVT 46.34
  • CING 41.97
  • Support Level
  • MCVT $1.91
  • CING $4.09
  • Resistance Level
  • MCVT $2.00
  • CING $4.39
  • Average True Range (ATR)
  • MCVT 0.06
  • CING 0.20
  • MACD
  • MCVT 0.01
  • CING -0.02
  • Stochastic Oscillator
  • MCVT 23.81
  • CING 0.22

About MCVT Mill City Ventures III Ltd.

Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: